Patent · US Active

Method for treating IFNalpha related conditions

US9993565B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

NEOVACS · FR

Inventors

Géraldine GROUARD-VOGEL · Paris, FR
Olivier Dhellin · Paris, FR
Bernard Fanget · Écully, FR
Pierre Vandepapeliere · Namur, BE
Camille Roucairol · Paris, FR

Key dates

Filing date	Apr 4, 2012
Grant date	Jun 12, 2018
Priority date	—
Expiry date	Apr 4, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/20031
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An immunogenic product including IFNα coupled to a carrier protein molecule is capable to induce in vivo anti-IFNα antibodies and is useful in treating IFNα related conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.